Literature DB >> 24634202

Causal attributions about disease onset and relapse in patients with systemic vasculitis.

Peter C Grayson1, Naomi A Amudala, Carol A McAlear, Renée L Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel, Peter A Merkel.   

Abstract

OBJECTIVE: Patients vary in their beliefs related to the cause of serious illness. The effect of these beliefs among patients with systemic vasculitis is not known. Our study aimed to describe causal attributions about disease onset and relapse in systemic vasculitis and to examine whether causal beliefs differ by type of vasculitis or are associated with negative health outcomes.
METHODS: Patients with vasculitis were recruited to complete an online questionnaire. Categories of causal beliefs were assessed with the Revised Illness Perception Questionnaire (IPQ-R). Differences in beliefs about disease onset versus relapse were compared across different forms of vasculitis. Causal beliefs were assessed in association with several health outcomes including fatigue, functional impairments, and personal understanding of the condition.
RESULTS: The questionnaire was completed by 692 patients representing 9 forms of vasculitis. The majority (90%) of patients had beliefs about the cause of their illness. Causal attributions were highly variable, but altered immunity and stress were the most commonly agreed-upon causal beliefs. Frequencies of causal beliefs were strikingly similar across different forms of vasculitis, with a few notable exceptions primarily in Behçet disease. Beliefs differed about causes of disease onset versus relapse. Specific beliefs about disease onset and relapse were weakly associated with fatigue, functional impairments, and understanding of the condition.
CONCLUSION: Patient beliefs related to the cause of systemic vasculitis are highly variable. Patterns of causal beliefs are associated with important negative health outcomes. Clinicians who care for patients with vasculitis should be mindful of these associations and consider asking about patients' causal beliefs.

Entities:  

Keywords:  CAUSAL ATTRIBUTIONS; ILLNESS PERCEPTIONS; VASCULITIS

Mesh:

Year:  2014        PMID: 24634202      PMCID: PMC4008683          DOI: 10.3899/jrheum.131096

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  27 in total

1.  Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis.

Authors:  N Molinari; I Koné Paut; R Manna; J Demaille; J P Daures; I Touitou
Journal:  Am J Med Genet A       Date:  2003-10-01       Impact factor: 2.802

2.  Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Michael Walsh; Oliver Flossmann; Annelies Berden; Kerstin Westman; Peter Höglund; Coen Stegeman; David Jayne
Journal:  Arthritis Rheum       Date:  2012-02

Review 3.  Primary systemic vasculitis.

Authors:  C O Savage; L Harper; D Adu
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

4.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

5.  An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

Authors:  E Reinhold-Keller; N Beuge; U Latza; K de Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal:  Arthritis Rheum       Date:  2000-05

6.  Familial aggregation of Behçet's disease in Turkey.

Authors:  A Gül; M Inanç; L Ocal; O Aral; M Koniçe
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

7.  Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis.

Authors:  Neil Basu; Gareth T Jones; Nick Fluck; Alan G MacDonald; Dong Pang; Paula Dospinescu; David M Reid; Gary J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2010-04-17       Impact factor: 7.580

8.  Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis.

Authors:  Maria Koutantji; Emma Harrold; Suzanne E Lane; Shirley Pearce; Richard A Watts; David G I Scott
Journal:  Arthritis Rheum       Date:  2003-12-15

9.  Patients' beliefs about the causes of systemic lupus erythematosus.

Authors:  Olivier Taïeb; Olivier Bricou; Thierry Baubet; Valérie Gaboulaud; Béatrice Gal; Luc Mouthon; Robin Dhote; Loïc Guillevin; Marie Rose Moro
Journal:  Rheumatology (Oxford)       Date:  2009-12-29       Impact factor: 7.580

10.  Factors affecting therapeutic compliance: A review from the patient's perspective.

Authors:  Jing Jin; Grant Edward Sklar; Vernon Min Sen Oh; Shu Chuen Li
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more
  5 in total

1.  Cancer Survivors' Beliefs About the Causes of Their Insomnia: Associations of Causal Attributions With Survivor Characteristics.

Authors:  Kelly M Shaffer; Allison J Applebaum; Katherine N DuHamel; Sheila N Garland; Philip Gehrman; Jun J Mao
Journal:  Behav Sleep Med       Date:  2018-11-26       Impact factor: 2.964

2.  Impact of vasculitis on employment and income.

Authors:  Lillian Barra; Renée L Borchin; Cristina Burroughs; George C Casey; Carol A McAlear; Antoine G Sreih; Kalen Young; Peter A Merkel; Christian Pagnoux
Journal:  Clin Exp Rheumatol       Date:  2018-01-10       Impact factor: 4.473

3.  Status epilepticus of inflammatory etiology: a cohort study.

Authors:  Marianna Spatola; Jan Novy; Renaud Du Pasquier; Josep Dalmau; Andrea O Rossetti
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

4.  Association of lifestyle elements with self-rated wellness and health status in patients with Behcet's disease.

Authors:  Maryam Masoumi; Reihane Tabaraii; Saeed Shakiba; Mansoureh Shakeri; Abbas Smiley
Journal:  BMC Rheumatol       Date:  2020-09-27

5.  Does illness perception associate with disease symptoms in Behçet's disease?

Authors:  Gonca Mumcu; Fedayi Yağar; Fatma Alibaz-Öner; Nevsun İnanç; Haner Direskeneli; Tulin Ergun
Journal:  Intern Emerg Med       Date:  2018-11-30       Impact factor: 3.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.